Insider · CIK 0001636975

Nassif David W.

Reports to the SEC for 3 companies · LEXINGTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001636975

Forms 4 and 5

Insider transactions

29 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-21	PHVSPharvaris N.V.G Gift	CFO / CLO	GGift	−500 sh	—	—	113,800
2026-09-21	PHVSPharvaris N.V.S Sale	CFO / CLO	SSale	−6,000 sh	$36.47	−$219K	114,300
2026-05-21	PHVSPharvaris N.V.S Sale	CFO / CLO	SSale	−10K sh	$30.31	−$303K	120,300
2022-02-08	Sio Gene Therapies Inc.Restricted Stock UnitsA Award	Director, Interim CEO, CFO	AAward	+547K sh	—	—	546,500
2021-12-08	Sio Gene Therapies Inc.Restricted Stock UnitsD Disposition to Issuer	Director, Interim CEO, CFO	DDisposition to Issuer	−17.5K sh	—	—	35,066
2021-12-08	Sio Gene Therapies Inc.F Tax Payment	Director, Interim CEO, CFO	FTax Payment	−6,294 sh	$1.42	−$8,937.48	45,244
2021-12-08	Sio Gene Therapies Inc.A Award	Director, Interim CEO, CFO	AAward	+17.5K sh	—	—	51,538
2021-04-15	Sio Gene Therapies Inc.Stock Option (Right to Buy)A Award	Director, Interim CEO, CFO	AAward	+239K sh	—	—	239,000
2021-03-22	Sio Gene Therapies Inc.A Award	Director, Interim CEO, CFO	AAward	+15.1K sh	—	—	34,004
2021-03-22	Sio Gene Therapies Inc.Restricted Stock UnitsD Disposition to Issuer	Director, Interim CEO, CFO	DDisposition to Issuer	−15.1K sh	—	—	0
2020-06-12	Sio Gene Therapies Inc.Restricted Stock UnitsD Disposition to Issuer	Director, Interim CEO, CFO	DDisposition to Issuer	−15.1K sh	—	—	15,060
2020-06-11	Sio Gene Therapies Inc.F Tax Payment	Director, Interim CEO, CFO	FTax Payment	−5,266 sh	$3.25	−$17.1K	18,944
2020-06-11	Sio Gene Therapies Inc.A Award	Director, Interim CEO, CFO	AAward	+15.1K sh	—	—	24,210
2020-04-15	Sio Gene Therapies Inc.Restricted Stock UnitsA Award	Director, Interim CEO, CFO	AAward	+52.6K sh	—	—	52,600
2020-04-15	Sio Gene Therapies Inc.Stock Option (Right to Buy)A Award	Director, Interim CEO, CFO	AAward	+78.9K sh	—	—	78,900
2019-09-21	Sio Gene Therapies Inc.Restricted Stock UnitsA Award	Director, Interim CEO, CFO	AAward	+30.1K sh	—	—	30,120
2019-07-01	Sio Gene Therapies Inc.Stock Option ( Right to Buy)A Award	Director, Interim CEO, CFO	AAward	+75K sh	—	—	75,000
2019-07-01	Sio Gene Therapies Inc.Stock Option (Right to Buy)A Award	Director, Interim CEO, CFO	AAward	+150K sh	—	—	150,000
2018-08-30	SteadyMed Ltd.Stock Option (Rt to Buy)J Other	EVP and CFO	JOther	−16K sh	—	—	0
2018-08-30	SteadyMed Ltd.Stock Option (Rt to Buy)J Other	EVP and CFO	JOther	−160K sh	—	—	0
2018-08-30	SteadyMed Ltd.S Sale	EVP and CFO	SSale	−22.2K sh	$4.46	−$98.8K	0
2018-08-30	SteadyMed Ltd.Stock Option (Rt to Buy)J Other	EVP and CFO	JOther	−3,100 sh	—	—	0
2018-08-30	SteadyMed Ltd.Stock Option (Rt to Buy)J Other	EVP and CFO	JOther	−40K sh	—	—	0
2018-08-30	SteadyMed Ltd.Stock Option (Rt to Buy)J Other	EVP and CFO	JOther	−51.8K sh	—	—	0
2018-07-05	SteadyMed Ltd.S Sale	EVP and CFO	SSale	−12.2K sh	$4.50	−$54.7K	22,157
2018-07-02	SteadyMed Ltd.S Sale	EVP and CFO	SSale	−10K sh	$4.50	−$45K	34,314
2017-12-28	SteadyMed Ltd.Stock Option (right to buy)A Award	EVP and CFO	AAward	+16K sh	—	—	15,987
2017-11-13	SteadyMed Ltd.A Award	EVP and CFO	AAward	+44.3K sh	—	—	44,315
2016-06-17	SteadyMed Ltd.Stock Option (Right to Buy)A Award	EVP and CFO	AAward	+40K sh	—	—	40,000

Recent filings

Accepted (ET)
Sep 234
Nassif David W.0001193125-26-398678
SEC(opens sec.gov)
May 264
Nassif David W.0001193125-26-239720
SEC(opens sec.gov)
Feb 104
Nassif David W.0001636050-22-000020
SEC(opens sec.gov)
Dec 94
Nassif David W.0001636050-21-000099
SEC(opens sec.gov)
Apr 194
Nassif David W.0001636050-21-000046
SEC(opens sec.gov)
Mar 224
Nassif David W.0001636050-21-000031
SEC(opens sec.gov)
Jun 154
Nassif David W.0001209191-20-036808
SEC(opens sec.gov)
Apr 174
Nassif David W.0001209191-20-025016
SEC(opens sec.gov)
Sep 244
Nassif David W.0001636050-19-000085
SEC(opens sec.gov)
Jul 24
Nassif David W.0001209191-19-040520
SEC(opens sec.gov)
Sep 44
Nassif David W.0001209191-18-049373
SEC(opens sec.gov)

Companies

Address

1 CRANBERRY HILL SUITE 400 LEXINGTON

LEXINGTON, MA, 02421